Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries

American Journal of Cardiology

Volumn 110, Issue 1, 2012, Pages 7-12

  Fauchier, Laurent ^a   Pellegrin, Céline ^a   Bernard, Anne ^a   Clementy, Nicolas ^a   Angoulvant, Denis ^a   Lip, Gregory Y H ^b   Babuty, Dominique ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ARTICLE; BARE METAL STENT; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; DEVICE SAFETY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84862281938     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.042     Document Type: Article

References (16)

1. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, F.H. Rutten Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology Eur Heart J 31 2010 2369 2429
2. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
3. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
4. PRISM-PLUS Study Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study N Engl J Med 338 1998 1488 1497
5. M.B. Leon, D.S. Baim, J.J. Popma, P.C. Gordon, D.E. Cutlip, K.K. Ho, A. Giambartolomei, D.J. Diver, D.M. Lasorda, D.O. Williams, S.J. Pocock, R.E. Kuntz A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671
6. J.M. Ruiz-Nodar, F. Marín, J. Sánchez-Payá, J.A. Hurtado, J. Valencia-Martín, S. Manzano-Fernández, V. Roldán, V. Pérez-Andreu, F. Sogorb, M. Valdés, G.Y. Lip Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation Eur Heart J 30 2009 932 939
7. J.V. Tu, J. Bowen, M. Chiu, D.T. Ko, P.C. Austin, Y. He, R. Hopkins, J.E. Tarride, G. Blackhouse, C. Lazzam, E.A. Cohen, R. Goeree Effectiveness and safety of drug-eluting stents in Ontario N Engl J Med 357 2007 1393 1402
8. E.P. McFadden, E. Stabile, E. Regar, E. Cheneau, A.T. Ong, T. Kinnaird, W.O. Suddath, N.J. Weissman, R. Torguson, K.M. Kent, A.D. Pichard, L.F. Satler, R. Waksman, P.W. Serruys Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
9. A.A. Bavry, D.J. Kumbhani, T.J. Helton, P.P. Borek, G.R. Mood, D.L. Bhatt Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials Am J Med 119 2006 1056 1061
10. S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, M. Pfeffer, S. Hohnloser, S. Yusuf The ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W) Lancet 367 2006 1903 1912
11. Z. Khurram, E. Chou, R. Minutello, G. Bergman, M. Parikh, S. Naidu, S.C. Wong, M.K. Hong Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding J Invasive Cardiol 18 2006 162 164
12. G.Y. Lip, K. Huber, F. Andreotti, H. Arnesen, K.J. Airaksinen, T. Cuisset, P. Kirchhof, F. Marín European Society of Cardiology Working Group on Thrombosis Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting Thromb Haemost 103 2010 13 28
13. A.A. Bavry, D.L. Bhatt Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis Lancet 371 2008 2134 2143
14. W. Dewilde, J.T. Berg Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST) Am Heart J 158 2009 713 718
15. S.D. Wiviott, E. Braunwald, C.H. McCabe, I. Horvath, M. Keltai, J.P. Herrman, de Van, F. Werf, W.E. Downey, B.M. Scirica, S.A. Murphy, E.M. Antman TRITON-TIMI 38 Investigators Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
16. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, L. Wallentin RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151